Sihuan Pharmaceutical Holdings Group Ltd. Press Release

Sihuan Pharmaceutical Was Selected As One Of The First Echelon Of Enterprises In The list of China's Top 100 Pharmaceutical Innovative Enterprises in 2023
Oct 13, 2023 18:07 JST

Sihuan Pharmaceutical (0460.HK) Announces 2023 Interim Results, Revenue amounted to RMB1,055.7 million Aug 31, 2023 13:50 JST Sihuan Pharmaceutical Holdings Group Ltd. (HKEx stock code: 0460) ("Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") announced its interim results for the period ended 30 June 2023 (the "Period"). More info..

Sihuan Pharmaceutical (0460.HK): Huisheng Biopharmaceutical's Drug Semaglutide Injection Obtained Approval For Clinical Trial
Jul 05, 2023 09:49 JST

Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, Its Innovative Drug Anaprozole Sodium Enteric-coated Tablets Obtains Drug Registration Approval From NMPA
Jun 27, 2023 13:00 JST

Sihuan Pharmaceutical Holdings Group Ltd. (the "Company" or "Sihuan Pharmaceutical", together with its subsidiaries, the "Group", HKEX stock code: 0460) is pleased to announce that Xuanzhu Biopharmaceutical Co., Ltd. ("Xuanzhu Biopharm"), a non-wholly owned subsidiary of Company, has received a drug registration approval from the National Medical Products Administration (the "NMPA") of China of Anaprozole Sodium Enteric-coated Tablet for the treatment of duodenal ulcer.
More info..

Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, progresses at full speed in innovative research and development, Presents major research results of birociclib, the start product, at the international stage in ASCO
Jun 08, 2023 21:18 JST

Sihuan Pharmaceutical Holdings Group Ltd. (the "Company" or "Sihuan Pharmaceutical", together with its subsidiaries, the "Group", HKEX stock code: 0460) is pleased to announce that the Group recently attended the 59th American Society of Clinical Oncology (ASCO) annual meeting in Chicago, the United States with its major research results
More info..

Sihuan Pharmaceutical (0460.HK) Announces 2022 Annual Results Mar 24, 2023 19:16 JST Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460) ("Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") announces its annual results for the year ended 31 December 2022 (the Year). More info..

Sihuan Pharmaceutical (0460.HK): Huisheng Biopharmaceutical Successfully Completes A+ Round of Financing, Accelerating the Layout of Diabetes and Complications
Jan 04, 2023 09:55 JST

Sihuan Pharmaceutical Holdings Group Co., Ltd. (the "Company" or "Sihuan Pharmaceutical", together with its subsidiaries, collectively referred to as the "Group"; stock code: 0460) is pleased to announce that the Group's Jilin Huisheng Biopharmaceutical Co., Ltd.
More info..

Sihuan Pharmaceutical (0460.HK): Respond to the special directives to combat illegal medical aesthetics services, Advocate 'Positive Energy' in China's Medical Aesthetics Industry
Aug 11, 2021 16:55 JST

On June 10, 2021, the National Health Commission, leading eight ministries and commissions, issued the "Notice on Distributing the Special Rectification Work Plan for Combating Illegal Medical Aesthetic Services."
More info..

Sihuan Pharmaceutical Launched an Equity Incentive Plan to Inject New Impetus for the Company's Growth Aug 27, 2020 16:05 JST Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460 "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") announced that on 26 August 2020 More info..

Sihuan Pharmaceutical Announces 2020 Interim Results Aug 25, 2020 21:26 JST Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460 "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce its interim results for the 6 months ended 30 June 2020 (the "Period"). More info..